Brand Reference: Glucophage, Glucophage XR, Fortamet
| Metric | Verified Benchmark | Source |
|---|---|---|
| Metformin Hydrochloride RxNorm Concept ID | 6809 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0412 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $24.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $5.40 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $7.50 / mo | 51 Zero-PHI Verified Patient Logs |
Inhibits hepatic mitochondrial respiratory-chain Complex I and glycerophosphate dehydrogenase, elevating AMP:ATP ratios to activate AMPK, suppressing hepatic gluconeogenesis, increasing intestinal GLP-1 release, and shifting gut Akkermansia muciniphila abundance.
Across 51 community cost disclosures for Metformin Hydrochloride (Glucophage / Glucophage XR / Fortamet), cash buyers routing around $24.00 retail markups capture a 78% discount ($5.40/mo benchmark vs $0.0412 NADAC acquisition).
Following administration (500 mg ER once daily), Metformin Hydrochloride achieves 50%–60% fasting oral bioavailability and 48–72 hours glycemic reduction onset, governed by a 6.2 hours plasma / 17.6 hours erythrocyte terminal half-life through zero hepatic metabolism; excreted unchanged via renal oct2/mate1 tubular secretion.
Before initiating Metformin Hydrochloride at 500 mg ER once daily, clinical safety checklists rule out egfr below 30 ml/min/1.73m2; acute metabolic acidosis or dka; decompensated hypoxic heart failure. Logged tolerability patterns center on loose stools (24% of reports), b12 depletion (chronic) (12% of reports), metallic taste (9% of reports).
Across 51 verified cash-pay logs, Metformin Hydrochloride achieves a 88.10% Worth-It rating with out-of-pocket spend averaging $7.50/mo versus $24.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 500 mg ER once daily for Metformin Hydrochloride; monthly out-of-pocket dropped to $4.75 compared with $24.00 retail.
Completed 10 weeks on Metformin Hydrochloride (1000 mg ER once daily). Zero notable side effects on steady dosing.
Consistent biomarker response on 1500 mg ER daily Metformin Hydrochloride sourced via Cost Plus Drugs ($6.26/mo cash pay without insurance prior authorization).